Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | REST corepressor 1 | Starlite/ChEMBL | References |
Homo sapiens | lysine (K)-specific demethylase 1A | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0083 | 0.3809 | 1 |
Echinococcus multilocularis | 0.0017 | 0.0494 | 0.1295 | |
Mycobacterium ulcerans | protoporphyrinogen oxidase | 0.0017 | 0.0494 | 0.5 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0024 | 0.0846 | 0.0871 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0494 | 0.0493 |
Brugia malayi | Myb-like DNA-binding domain containing protein | 0.02 | 0.9706 | 1 |
Mycobacterium ulcerans | oxidoreductase | 0.0017 | 0.0494 | 0.5 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.0017 | 0.0494 | 0.5 |
Echinococcus multilocularis | protoporphyrinogen oxidase | 0.0017 | 0.0494 | 0.1295 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0083 | 0.3809 | 1 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0017 | 0.0494 | 0.5 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0017 | 0.0494 | 0.1295 |
Schistosoma mansoni | amine oxidase | 0.0017 | 0.0494 | 0.1295 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0017 | 0.0494 | 1 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0083 | 0.3809 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0 | 0.5 |
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.0017 | 0.0494 | 0.1295 |
Entamoeba histolytica | SWIRM domain protein | 0.0007 | 0 | 0.5 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.0017 | 0.0494 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0017 | 0.0494 | 0.5 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0017 | 0.0494 | 0.5 |
Mycobacterium ulcerans | monoamine oxidase | 0.0017 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0083 | 0.3809 | 0.3809 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0017 | 0.0494 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0017 | 0.0494 | 0.5 |
Schistosoma mansoni | amine oxidase | 0.0017 | 0.0494 | 0.1295 |
Onchocerca volvulus | CoRest homolog | 0.0206 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0007 | 0 | 0.5 |
Brugia malayi | SWIRM domain containing protein | 0.009 | 0.4161 | 0.4287 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0017 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0494 | 0.0493 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0017 | 0.0494 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0017 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.02 | 0.9706 | 0.9706 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0017 | 0.0494 | 0.5 |
Giardia lamblia | hypothetical protein | 0.0007 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0017 | 0.0494 | 0.5 |
Leishmania major | UDP-galactopyranose mutase | 0.0017 | 0.0494 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0017 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0846 | 0.0845 |
Brugia malayi | hypothetical protein | 0.0017 | 0.0494 | 0.0508 |
Mycobacterium ulcerans | dehydrogenase | 0.0017 | 0.0494 | 0.5 |
Entamoeba histolytica | SWIRM domain protein | 0.0007 | 0 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0017 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0083 | 0.3809 | 0.3809 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.4161 | 0.4161 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0017 | 0.0494 | 1 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0017 | 0.0494 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | = 15.1 % | Inhibition of recombinant LSD1/CoREST (unknown origin) assessed as residual activity at 10 uM incubated for 30 mins to 4 hrs by fluorescence based assay relative to control | ChEMBL. | 25580204 |
Activity (binding) | = 0.96 molar ratio | Binding affinity to LSD1 (unknown origin) assessed as molar ratio for binding by nanoisothermal titration calorimetric method | ChEMBL. | 25580204 |
IC50 (binding) | = 1.19 uM | Inhibition of recombinant LSD1/CoREST (unknown origin) assessed as residual activity for 30 mins to 4 hrs by fluorescence based assay relative to control | ChEMBL. | 25580204 |
IC50 (functional) | = 12 uM | Cytotoxicity against human MDA-MB-231 cells assessed as cell viability incubated for 48 to 72 hrs by MTS method | ChEMBL. | 25580204 |
IC50 (functional) | = 74 uM | Cytotoxicity against human PC3 cells assessed as cell viability incubated for 48 to 72 hrs by MTS method | ChEMBL. | 25580204 |
IC50 (binding) | > 100 uM | Inhibition of MAOA (unknown origin) by luminiscent assay | ChEMBL. | 25580204 |
IC50 (binding) | > 100 uM | Inhibition of MAOB (unknown origin) by luminiscent assay | ChEMBL. | 25580204 |
Ka (binding) | = 48.89 nM | Binding affinity to LSD1 (unknown origin) by nanoisothermal titration calorimetric method | ChEMBL. | 25580204 |
Ki (binding) | = 2.2 uM | Competitive inhibition of LSD1 (unknown origin) incubated for 30 mins using H3K4me2 substrate by fluorescence based assay | ChEMBL. | 25580204 |
Vmax (binding) | = 30.62 U/min | Competitive inhibition of LSD1 (unknown origin) assessed as enzymatic Vmax incubated for 30 mins using H3K4me2 substrate by fluorescence based assay | ChEMBL. | 25580204 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 25580204 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.